Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Many cancer therapies function by activating proteins like Caspase-3 (CASP3) that promote cell death.
Several forms of cancer develop resistance to these drugs by down regulating CASP3 through an unknown mechanism.
In the absence of CASP3, tumor cells produce another cell death promoting protein CASP7, but it is rendered inactive by the X-linked inhibitor of apoptosis protein (XIAP).
In this issue of the Journal of Clinical Investigation, Po-Huang Liang and colleagues at Academia Sinica identify a compound (I-Lys) that disrupts the interaction between CASP7 and XIAP. Release of CASP7 from this complex in drug resistant cancer cells activated cell death and reduced malignancies.
Furthermore, no adverse side effects were observed in non-tumor cells treated with the drug.
In the accompanying commentary, Gregory Gores from the Mayo Clinic explains that these results are promising for combatting drug resistant cancers, but more work needs to be done to establish if I-Lys will be safe and beneficial for human use.
TITLE: Targeting the XIAP/caspase-7 complex selectively kills caspase-3-deficient malignancies J Clin Invest. doi:10.1172/JCI67951
ACCOMPANYING COMMENTARY TITLE: Unshackling caspase-7 for cancer therapy J Clin Invest. 2013;123(9):3706-3708. doi:10.1172/JCI71440
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Cancer / Oncology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
Journal of Clinical Investigation. "Combating drug-resistant cancers." Medical News Today. MediLexicon, Intl., 29 Aug. 2013. Web.
7 Dec. 2013. <http://www.medicalnewstoday.com/releases/265316>
Journal of Clinical Investigation. (2013, August 29). "Combating drug-resistant cancers." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/265316.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.